Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Phase 2, Multi-centre, Randomised, Double-masked, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of GSK933776 in Adult Patients With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Status: Enrolling
Updated:  4/14/2016
GSK Investigational Site
mi
from
Salt Lake City, UT
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Phase 2, Multi-centre, Randomised, Double-masked, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of GSK933776 in Adult Patients With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Status: Enrolling
Updated: 4/14/2016
GSK Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Phase 2, Multi-centre, Randomised, Double-masked, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of GSK933776 in Adult Patients With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Status: Enrolling
Updated:  4/14/2016
GSK Investigational Site
mi
from
Charlottesville, VA
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Phase 2, Multi-centre, Randomised, Double-masked, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of GSK933776 in Adult Patients With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Status: Enrolling
Updated: 4/14/2016
GSK Investigational Site
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Phase 2, Multi-centre, Randomised, Double-masked, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of GSK933776 in Adult Patients With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Status: Enrolling
Updated:  4/14/2016
GSK Investigational Site
mi
from
Silverdale, WA
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Phase 2, Multi-centre, Randomised, Double-masked, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of GSK933776 in Adult Patients With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Status: Enrolling
Updated: 4/14/2016
GSK Investigational Site
mi
from
Silverdale, WA
Click here to add this to my saved trials
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Phase 2, Multi-centre, Randomised, Double-masked, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of GSK933776 in Adult Patients With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Status: Enrolling
Updated:  4/14/2016
GSK Investigational Site
mi
from
Mississauga,
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Phase 2, Multi-centre, Randomised, Double-masked, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of GSK933776 in Adult Patients With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Status: Enrolling
Updated: 4/14/2016
GSK Investigational Site
mi
from
Mississauga,
Click here to add this to my saved trials
Correction of Myopia Evaluation Trial (COMET)
Correction of Myopia Evaluation Trial (COMET)
Status: Enrolling
Updated:  4/14/2016
University of Alabama-Birmingham, School of Optometry
mi
from
Birmingham, AL
Correction of Myopia Evaluation Trial (COMET)
Correction of Myopia Evaluation Trial (COMET)
Status: Enrolling
Updated: 4/14/2016
University of Alabama-Birmingham, School of Optometry
mi
from
Birmingham, AL
Click here to add this to my saved trials
Correction of Myopia Evaluation Trial (COMET)
Correction of Myopia Evaluation Trial (COMET)
Status: Enrolling
Updated:  4/14/2016
New England College of Optometry
mi
from
Boston, MA
Correction of Myopia Evaluation Trial (COMET)
Correction of Myopia Evaluation Trial (COMET)
Status: Enrolling
Updated: 4/14/2016
New England College of Optometry
mi
from
Boston, MA
Click here to add this to my saved trials
Correction of Myopia Evaluation Trial (COMET)
Correction of Myopia Evaluation Trial (COMET)
Status: Enrolling
Updated:  4/14/2016
Pennsylvania College of Optometry
mi
from
Philadelphia, PA
Correction of Myopia Evaluation Trial (COMET)
Correction of Myopia Evaluation Trial (COMET)
Status: Enrolling
Updated: 4/14/2016
Pennsylvania College of Optometry
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Correction of Myopia Evaluation Trial (COMET)
Correction of Myopia Evaluation Trial (COMET)
Status: Enrolling
Updated:  4/14/2016
University of Houston, College of Optometry
mi
from
Houston, TX
Correction of Myopia Evaluation Trial (COMET)
Correction of Myopia Evaluation Trial (COMET)
Status: Enrolling
Updated: 4/14/2016
University of Houston, College of Optometry
mi
from
Houston, TX
Click here to add this to my saved trials
Use of Ranibizumab With Mitomycin C During Trabeculectomy
Occlusion Prevention for Trabeculectomy Procedures Using Combination Ranibizumab and Mitomycin C (MMC) During Surgery (OCTOPUS Study)
Status: Enrolling
Updated:  4/18/2016
Rocky Mountain Lions Eye Institute
mi
from
Aurora, CO
Use of Ranibizumab With Mitomycin C During Trabeculectomy
Occlusion Prevention for Trabeculectomy Procedures Using Combination Ranibizumab and Mitomycin C (MMC) During Surgery (OCTOPUS Study)
Status: Enrolling
Updated: 4/18/2016
Rocky Mountain Lions Eye Institute
mi
from
Aurora, CO
Click here to add this to my saved trials
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated:  4/18/2016
Vold Vision, PLLC
mi
from
Springdale, AR
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated: 4/18/2016
Vold Vision, PLLC
mi
from
Springdale, AR
Click here to add this to my saved trials
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated:  4/18/2016
University of California, Irvine
mi
from
Irvine, CA
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated: 4/18/2016
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated:  4/18/2016
Yale University
mi
from
New Haven, CT
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated: 4/18/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated:  4/18/2016
Illinois Eye Institute
mi
from
Chicago, IL
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated: 4/18/2016
Illinois Eye Institute
mi
from
Chicago, IL
Click here to add this to my saved trials
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated:  4/18/2016
Glaucoma Associates of New York
mi
from
New York, NY
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated: 4/18/2016
Glaucoma Associates of New York
mi
from
New York, NY
Click here to add this to my saved trials
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated:  4/18/2016
Ophthalmic Partners of Pennsylvania
mi
from
Bala Cynwyd, PA
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated: 4/18/2016
Ophthalmic Partners of Pennsylvania
mi
from
Bala Cynwyd, PA
Click here to add this to my saved trials
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated:  4/18/2016
University Eye Surgeons
mi
from
Maryville, TN
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated: 4/18/2016
University Eye Surgeons
mi
from
Maryville, TN
Click here to add this to my saved trials
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated:  4/18/2016
Glaucoma Associates of Texas
mi
from
Dallas, TX
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated: 4/18/2016
Glaucoma Associates of Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated:  4/18/2016
University of Virginia
mi
from
Charlottsville, VA
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated: 4/18/2016
University of Virginia
mi
from
Charlottsville, VA
Click here to add this to my saved trials
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated:  4/18/2016
Memmen, Ltd
mi
from
Green Bay, WI
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated: 4/18/2016
Memmen, Ltd
mi
from
Green Bay, WI
Click here to add this to my saved trials
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated:  4/18/2016
University of Alabama
mi
from
Birmingham, AL
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated: 4/18/2016
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated:  4/18/2016
University of Campinas
mi
from
Campinas,
SOLX Gold Shunt for Refractory Glaucoma
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Status: Enrolling
Updated: 4/18/2016
University of Campinas
mi
from
Campinas,
Click here to add this to my saved trials
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Status: Enrolling
Updated:  4/18/2016
Phoenix Eye Care, PLLC
mi
from
Phoenix, AZ
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Status: Enrolling
Updated: 4/18/2016
Phoenix Eye Care, PLLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Status: Enrolling
Updated:  4/18/2016
Lake Zurich Eye Care
mi
from
Lake Zurich, IL
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Status: Enrolling
Updated: 4/18/2016
Lake Zurich Eye Care
mi
from
Lake Zurich, IL
Click here to add this to my saved trials
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Status: Enrolling
Updated:  4/18/2016
Drs. Quinn, Foster & Assoc.
mi
from
Athens, OH
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Status: Enrolling
Updated: 4/18/2016
Drs. Quinn, Foster & Assoc.
mi
from
Athens, OH
Click here to add this to my saved trials
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Status: Enrolling
Updated:  4/18/2016
Vision Professionals
mi
from
New Albany, OH
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Status: Enrolling
Updated: 4/18/2016
Vision Professionals
mi
from
New Albany, OH
Click here to add this to my saved trials
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Status: Enrolling
Updated:  4/20/2016
University of Miami
mi
from
Miami, FL
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Status: Enrolling
Updated: 4/20/2016
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Status: Enrolling
Updated:  4/20/2016
Wilmer Eye Institute, Johns Hopkins University
mi
from
Baltimore, MD
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Status: Enrolling
Updated: 4/20/2016
Wilmer Eye Institute, Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Status: Enrolling
Updated:  4/20/2016
Montefiore Medical Center
mi
from
Bronx, NY
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Status: Enrolling
Updated: 4/20/2016
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Status: Enrolling
Updated:  4/20/2016
Scheie Eye Institute, University of Pennsylvania
mi
from
Philadelphia, PA
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Status: Enrolling
Updated: 4/20/2016
Scheie Eye Institute, University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Status: Enrolling
Updated:  4/20/2016
University of California at San Francisco
mi
from
San Francisco, CA
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Status: Enrolling
Updated: 4/20/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Status: Enrolling
Updated:  4/20/2016
Oregon Health and Sciences University
mi
from
Portland, OR
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study
Status: Enrolling
Updated: 4/20/2016
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Status: Enrolling
Updated:  4/20/2016
Ophthalmic Consultants of Long Island
mi
from
Lynbrook, NY
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Status: Enrolling
Updated: 4/20/2016
Ophthalmic Consultants of Long Island
mi
from
Lynbrook, NY
Click here to add this to my saved trials
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Inglewood, CA
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Inglewood, CA
Click here to add this to my saved trials
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Cape Coral, FL
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Cape Coral, FL
Click here to add this to my saved trials
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Roswell, GA
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Roswell, GA
Click here to add this to my saved trials
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
St Joseph, MI
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
St Joseph, MI
Click here to add this to my saved trials
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Memphis, TN
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
DAILIES TOTAL1® - Comparative Assessment of Tear Film Evaporation
Pilot Study on the Effect of Daily Disposable Silicone Hydrogel Contact Lenses on Tear Film Lipids
Status: Enrolling
Updated:  4/28/2016
Contact Alcon Call Center for Trial Locations
mi
from
Fort Worth, TX
DAILIES TOTAL1® - Comparative Assessment of Tear Film Evaporation
Pilot Study on the Effect of Daily Disposable Silicone Hydrogel Contact Lenses on Tear Film Lipids
Status: Enrolling
Updated: 4/28/2016
Contact Alcon Call Center for Trial Locations
mi
from
Fort Worth, TX
Click here to add this to my saved trials
AP-05-002 A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug)in the Treatment of Diabetic Macular Edema
A Randomized, Placebo-Controlled, Parallel, Double-Masked Study to Evaluate the Efficacy and Safety of Two Doses of Oral Optina in Adult Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  5/4/2016
Vaughan Clift
mi
from
Englewood, CO
AP-05-002 A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug)in the Treatment of Diabetic Macular Edema
A Randomized, Placebo-Controlled, Parallel, Double-Masked Study to Evaluate the Efficacy and Safety of Two Doses of Oral Optina in Adult Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 5/4/2016
Vaughan Clift
mi
from
Englewood, CO
Click here to add this to my saved trials
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated:  5/4/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated: 5/4/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated:  5/4/2016
Eye Elements Eyecare
mi
from
Jacksonville, FL
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated: 5/4/2016
Eye Elements Eyecare
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated:  5/4/2016
Golden Vision
mi
from
Sarasota, FL
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated: 5/4/2016
Golden Vision
mi
from
Sarasota, FL
Click here to add this to my saved trials
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated:  5/4/2016
Advantage Eyecare Associates, LLC
mi
from
Neodesha, KA
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated: 5/4/2016
Advantage Eyecare Associates, LLC
mi
from
Neodesha, KA
Click here to add this to my saved trials
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated:  5/4/2016
Advanced Eyecare, PC
mi
from
Raytown, MO
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated: 5/4/2016
Advanced Eyecare, PC
mi
from
Raytown, MO
Click here to add this to my saved trials
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated:  5/4/2016
Professional Vision Care
mi
from
Westerville, OH
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated: 5/4/2016
Professional Vision Care
mi
from
Westerville, OH
Click here to add this to my saved trials
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated:  5/4/2016
Timothy R. Poling, OD
mi
from
Roanoke, VA
Clinical Evaluation of Approved Contact Lenses
Status: Enrolling
Updated: 5/4/2016
Timothy R. Poling, OD
mi
from
Roanoke, VA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
NVISION Camarillo
mi
from
Camarillo, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Camarillo
mi
from
Camarillo, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
NVISION Sacramento
mi
from
Citrus Heights, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Sacramento
mi
from
Citrus Heights, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
NVISION Fullerton
mi
from
Fullerton, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Fullerton
mi
from
Fullerton, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
NVISION Laguna Hills
mi
from
Laguna Hills, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Laguna Hills
mi
from
Laguna Hills, CA
Click here to add this to my saved trials